Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c512
Identifier NCT05494606
Trial Title An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions -
Participant Information
Sponsor AbbVie
City Ciudad Autonoma de Buenos Aire
Country/Region Argentina
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2022-08-15
Primary Completion Date 2025-03-28
Completion Date 2025-03-28